中国酒精性肝病负担日益加重：综述。
Growing burden of alcoholic liver disease in China: A review.
机构信息
Department of Hepatology, First Hospital of Jilin University, Jilin University, Changchun 130021, Jilin Province, China.
出版信息
World J Gastroenterol. 2019 Mar 28;25(12):1445-1456. doi: 10.3748/wjg.v25.i12.1445.
Abstract
Explosive economic growth and increasing social openness in China over the last 30 years have significantly boosted alcohol consumption, and consequently, the incidence of alcoholic liver disease (ALD) in China has increased. Because the epidemiologic and clinical features of ALD in the Chinese population may differ from those of the Caucasian population, this review describes the epidemiology, pathogenesis, genetic polymorphisms, diagnosis, and treatment of ALD in the Chinese population. This updated knowledge of ALD in China provides information needed for a global understanding of ALD and may help in the development of useful strategies for reducing the global ALD burden.
摘要
过去 30 年来，中国经济的爆炸式增长和社会的日益开放极大地促进了酒精消费，由此导致中国的酒精性肝病（ALD）发病率上升。由于中国人群的 ALD 的流行病学和临床特征可能与白种人群不同，因此本综述描述了中国人群的 ALD 的流行病学、发病机制、遗传多态性、诊断和治疗。中国人群 ALD 的这些最新知识提供了对 ALD 进行全球理解所需的信息，并可能有助于制定有用的策略来减轻全球 ALD 负担。
相似文献
1
Growing burden of alcoholic liver disease in China: A review.中国酒精性肝病负担日益加重：综述。
World J Gastroenterol. 2019 Mar 28;25(12):1445-1456. doi: 10.3748/wjg.v25.i12.1445.
2
Correlation of polymorphism in the interleukin-1 receptor antagonist gene intron 2 with alcoholic liver disease.白细胞介素-1受体拮抗剂基因内含子2多态性与酒精性肝病的相关性
Hepatobiliary Pancreat Dis Int. 2005 Feb;4(1):41-5.
3
Focus on alcoholic liver disease: from nosography to treatment.聚焦酒精性肝病：从疾病分类学到治疗
World J Gastroenterol. 2014 Jul 7;20(25):8040-7. doi: 10.3748/wjg.v20.i25.8040.
4
Prevalence of alcoholic liver disease and its association with socioeconomic status in north-eastern China.中国东北地区酒精性肝病的患病率及其与社会经济地位的关系。
Alcohol Clin Exp Res. 2014 Apr;38(4):1035-41. doi: 10.1111/acer.12321. Epub 2014 Jan 15.
5
Genetic polymorphism of two enzymes with alcoholic liver disease in Northeast China.中国东北地区两种酶与酒精性肝病的基因多态性
Hepatogastroenterology. 2012 Jan-Feb;59(113):204-7. doi: 10.5754/hge10136.
6
Epidemiology of alcoholic and nonalcoholic fatty liver disease in China.中国酒精性和非酒精性脂肪性肝病的流行病学。
J Gastroenterol Hepatol. 2013 Aug;28 Suppl 1:11-7. doi: 10.1111/jgh.12036.
7
Alcoholic liver disease and hepatitis C virus infection.酒精性肝病与丙型肝炎病毒感染
World J Gastroenterol. 2016 Jan 28;22(4):1411-20. doi: 10.3748/wjg.v22.i4.1411.
8
Epidemiological Realities of Alcoholic Liver Disease: Global Burden, Research Trends, and Therapeutic Promise.酒精性肝病的流行病学现状：全球负担、研究趋势和治疗前景。
Gene Expr. 2020 Nov 11;20(2):105-118. doi: 10.3727/105221620X15952664091823. Epub 2020 Jul 20.
9
Risk factors for alcoholic liver disease in China.中国酒精性肝病的危险因素。
World J Gastroenterol. 2004 Aug 15;10(16):2423-6. doi: 10.3748/wjg.v10.i16.2423.
10
Alcohol use in Hefei in relation to alcoholic liver disease: A multivariate logistic regression analysis.合肥地区饮酒与酒精性肝病的关系：多变量 logistic 回归分析。
Alcohol. 2018 Sep;71:1-4. doi: 10.1016/j.alcohol.2017.08.001. Epub 2017 Aug 12.
引用本文的文献
1
Integrating Strategy of Network Pharmacology, Molecular Dynamics Simulation, and Experimental Verification to Investigate the Potential Mechanism of Against Alcoholic Liver Injury.整合网络药理学、分子动力学模拟和实验验证策略以探究[具体药物或物质]抗酒精性肝损伤的潜在机制
Foods. 2025 Jun 6;14(12):2008. doi: 10.3390/foods14122008.
2
Association between weight fluctuation and the risk of metabolic dysfunction-associated steatotic liver disease.体重波动与代谢功能障碍相关脂肪性肝病风险之间的关联。
World J Hepatol. 2025 May 27;17(5):103852. doi: 10.4254/wjh.v17.i5.103852.
3
Recent advances in the role of polysaccharides in liver diseases: a review.多糖在肝脏疾病中作用的最新进展：综述
Front Pharmacol. 2025 Mar 27;16:1535717. doi: 10.3389/fphar.2025.1535717. eCollection 2025.
4
Selenium enrichment enhances the alleviating effect of GG on alcoholic liver injury in mice.富硒增强了GG对小鼠酒精性肝损伤的缓解作用。
Curr Res Food Sci. 2024 Dec 18;10:100964. doi: 10.1016/j.crfs.2024.100964. eCollection 2025.
5
New Insights into the Pathogenesis of Alcoholic Liver Disease Based on Global Research.基于全球研究对酒精性肝病发病机制的新见解
Dig Dis Sci. 2025 Mar;70(3):903-918. doi: 10.1007/s10620-024-08778-y. Epub 2025 Jan 13.
6
Etiology and Prognostic Criteria for Liver Failure in Southeast China: A Multicenter Retrospective Cohort Study Between 2018 and 2020.中国东南部肝衰竭的病因及预后标准：一项2018年至2020年的多中心回顾性队列研究
Gastroenterol Res Pract. 2024 Dec 18;2024:5512889. doi: 10.1155/grp/5512889. eCollection 2024.
7
Changes in the etiology of liver cirrhosis and the corresponding management strategies.肝硬化病因的变化及相应的管理策略。
World J Hepatol. 2024 Feb 27;16(2):146-151. doi: 10.4254/wjh.v16.i2.146.
8
Grouping motivational interviewing is only effective for younger patients with alcohol dependence in the rehabilitation stage.分组动机性访谈仅对处于康复阶段的年轻酒精依赖患者有效。
Eur Arch Psychiatry Clin Neurosci. 2025 Mar;275(2):431-438. doi: 10.1007/s00406-023-01736-1. Epub 2023 Dec 20.
9
Estimated projection of incidence and mortality of alcohol-related liver disease in China from 2022 to 2040: a modeling study.2022 年至 2040 年中国酒精性肝病发病和死亡的预估：一项建模研究。
BMC Med. 2023 Jul 27;21(1):277. doi: 10.1186/s12916-023-02984-7.
10
Epidemiological characteristics of alcohol-related liver disease in China: a systematic review and meta-analysis.中国酒精性肝病的流行病学特征：系统评价和荟萃分析。
BMC Public Health. 2023 Jul 1;23(1):1276. doi: 10.1186/s12889-023-15645-4.
本文引用的文献
1
Distribution of hepatitis B virus genotypes in Europe and clinical implications: a review.欧洲乙型肝炎病毒基因型分布及其临床意义：综述
Acta Dermatovenerol Alp Pannonica Adriat. 2018 Sep;27(3):141-146.
2
The changing epidemiology of liver diseases in the Asia-Pacific region.亚太地区肝脏疾病的不断变化的流行病学。
Nat Rev Gastroenterol Hepatol. 2019 Jan;16(1):57-73. doi: 10.1038/s41575-018-0055-0.
3
Single-nucleotide rs738409 polymorphisms in the PNPLA3 gene are strongly associated with alcoholic liver disease in Han Chinese males.单核苷酸 rs738409 多态性与汉族男性酒精性肝病密切相关。
Hepatol Int. 2018 Sep;12(5):429-437. doi: 10.1007/s12072-018-9889-3. Epub 2018 Aug 21.
4
Alcohol inhibits T-cell glucose metabolism and hepatitis in ALDH2-deficient mice and humans: roles of acetaldehyde and glucocorticoids.乙醛和糖皮质激素在缺乏 ALDH2 的小鼠和人群中抑制 T 细胞糖代谢和肝炎：酒精的作用。
Gut. 2019 Jul;68(7):1311-1322. doi: 10.1136/gutjnl-2018-316221. Epub 2018 Aug 18.
5
Alcoholic liver disease.酒精性肝病。
Nat Rev Dis Primers. 2018 Aug 16;4(1):16. doi: 10.1038/s41572-018-0014-7.
6
Disparities in mortality for chronic liver disease among Asian subpopulations in the United States from 2007 to 2016.2007 年至 2016 年美国亚洲亚群人群慢性肝病死亡率的差异。
J Viral Hepat. 2018 Dec;25(12):1608-1616. doi: 10.1111/jvh.12981. Epub 2018 Sep 11.
7
N-acetyl cysteine in the treatment of alcohol use disorder in patients with liver disease: Rationale for further research.N-乙酰半胱氨酸治疗肝病患者酒精使用障碍：进一步研究的理由。
Expert Opin Investig Drugs. 2018 Aug;27(8):667-675. doi: 10.1080/13543784.2018.1501471. Epub 2018 Aug 1.
8
Misconceptions, preferences and barriers to alcohol use disorder treatment in alcohol-related cirrhosis.酒精性肝硬化患者对酒精使用障碍治疗的误解、偏好和障碍。
J Subst Abuse Treat. 2018 Aug;91:20-27. doi: 10.1016/j.jsat.2018.05.003. Epub 2018 May 18.
9
[Guidelines of prevention and treatment for alcoholic liver disease: a 2018 update].[酒精性肝病防治指南：2018年更新版]
Zhonghua Gan Zang Bing Za Zhi. 2018 Mar 20;26(3):188-194. doi: 10.3760/cma.j.issn.1007-3418.2018.03.007.
10
Outcomes of Early Liver Transplantation for Patients With Severe Alcoholic Hepatitis.早期肝移植治疗重症酒精性肝炎患者的结局。
Gastroenterology. 2018 Aug;155(2):422-430.e1. doi: 10.1053/j.gastro.2018.04.009. Epub 2018 Apr 12.
Zotero 插件